I earnings position, opportunity, call. forward this look my I we talented Thank pleased you, our compelling financial working discipline annual on our can of increase very processes and improve participate team. growth and market because LifeStance joined Ken. with multi-year am significant to mission, that to commitments. our so to our unique I company first its team in deliver consistently and planning
XX% per Total LifeStance increased visit higher volumes in XX% increased productivity. our top of $XXX. turning year driven to the quarter of than Visit performance. results. count line outperformance strong year-over Now, to increased the with and million quarter $XXX X,XXX,XXX X% by fourth primarily clinician Revenue expected year-over-year, revenue year-over year. delivered
Our basis materials our visit. revenue look beginning metrics and forward forward. Therefore, function posted to total first a quarterly of is the volumes with a quarter these the information, XXXX, Historical to on going visit of earnings website. is revenue in reporting per provided we
we delivered of For up XX% year, year-over-year. full the revenue million, $XXX
Additionally, a was by flowed EBITDA our XX% $XX year-over-year. the through of quarter team. previously and Center XX% G&A Full such included as cycle the at million the quarter investments of These $XX end our management Center was the of better-than-expected Margin $XXX higher as year across growing revenue line than expected. top result, in results business guidance and were the range, investments Adjusted high year-over-year. increased million Margin. grew in of to Center Margin million accelerated,
full year, X.X% revenue. the adjusted million, of representing $XX For was EBITDA
liquidity. free quarter, of million In cash and Turning flow from cash we $XX to fourth $XX activities. the generated in million, operating positive
improved Ken driven were positive improvements by in mentioned, collections. As these cash flow
a it see encouraged by investment progress as our this are tangible team. and We in this return on
to that $X.X and DSO Our days each million. highlight represents fell like these by X days of one I’d quarter-over-quarter, roughly
Additionally, openings. capital pace of the with consistent moderating expenditures of our were novo de center strategy
with $XXX million long-term and million. We exited debt of net $XXX the of quarter cash
a sufficient have loan as We from $XX well million providing as flexibility. financial us of debt delayed-draw $XX additional million capacity with debt revolving facility, a term
for expect EBITDA In $XXX full year our $XX and $XX to $X.XX to of Adjusted XXXX, terms revenue we $XXX million Margin of billion, of $XXX million, outlook Center million. to of
modest clinicians revenue in combined assumes growth assuming primarily per generally increase guidance annual year-over-year. consistent are Otherwise, total higher the visit. revenue performance Our by visits with we year-over-year and operational a driven
revenue year half a second contemplates split roughly of and in the first also to the guidance seasonality. of due Our XX/XX
to at invest higher margins in a the than depressing rate as which grow we business, revenue We is strengthening expect year-over-year. G&A
For to $XX $XX the Margin first and quarter, million, we expect Center revenue of $X EBITDA of $XXX $XXX to to of Adjusted million, million. $XX
to to seasonality our We taxes expect margins quarter of some services EBITDA reset payroll patient of the to be first deductibles. down adjusted due related sequentially due to and
half of earnings the second We also improve to support investments year. quarter, resulting first in half business. to more expect expect the modestly in driven remainder then by incremental the of the first year, margins the the versus additional in for We expenses the G&A
approximately we in $XX $XX expect to expense new stock-based compensation $XXX including million the approximately from grants. XXXX million Additionally, of XXXX,
spend For of $XX of acquisitions. from million, the to up earn-outs years’ year, $XX million approximately prior M&A in we are expecting inclusive
sheet not have raise continue strong to We do anticipate in the need capital and XXXX. a to balance
funding driven second, such increase flow compensation the taxes, half free the as costs January. factors: in We temporarily of cash and two in have bonus in negative an first responsibility reset XXX(k); deductibles and year, the to the DSO by by expect of driven higher payments primarily payroll as first, patient higher
from absence first the year generate along half in these half cash DSO free of improving We costs, expect quarter first levels. flow to with positive second the the with of
Ken continue achieving serve LifeStance members, make clinicians As while will grow. to highlighted, benefits believe as significant imperative to and that to which deliver long-term strategic investments we our patients, enable areas those it’s we leverage in operating team better
our health identified an XX occur will or We investments employees, of months. critical system effectively credentialing and of lifecycle onboarding implementing to record HRIS have EHR entire the are, platform experience. two, enables clinicians, the that three XX These implementing next manage enhancing investments electronic our that to technology three and over a one,
implemented, a add-back will these Adjusted through for strategic Once as the costs calculate ongoing item We spend non-recurring to the G&A. EBITDA. initiatives come as discrete will identify
of planning onboarding. platform in supports credentialing the that and and the phases are the We and technology HRIS implementation
in to We as initiative the of in be million. with majority the this, the with We is Of to a anticipate $X.X CapEx. expect the EHR early those $X the $X of year. remainder very of next million cost investment to in recognized stages discovery. this be be expenses will XX to that months incurred will completed approximately The $X.X XX G&A
We our vendor a from to solution. expect alternative XXXX use evaluate an to vendor range of implementing collaborating options, to most of current with
provide estimated XXXX update we will for timeline the initiative. our when path forward, We guidance you on and EHR costs
is going to all, be year. a in busy All XXXX
key know building are we future. there and this committed, We company are our ambitious, initiatives. and a we to ahead, bright is going we and execute for growth are long are We on significant
capture that fully organic we We opportunity. to deliver being will ensure XXXX, for that make with the way investments mid-teens we along the future through revenue X level expect M&A years, X incremental outlook In to the necessary next growth. to potential of growth regards to our to annual
We expansion expect XXXX. of and higher such XXXX digit The improvement margin with margin with trajectory margins mental improvement growth leverage, therapy. material by levels by as in XXXX the double end payors, driven from offerings, rate and group of be neuropsych current Adjusted testing to and will EBITDA a operating health
We positive be to growth. well cash free both expect as to organic M&A fund XXXX as for moderate flow
Danish turn operations. to With additional for respect to over with that, I’ll it color